메뉴 건너뛰기




Volumn 42, Issue 1, 2003, Pages 17-23

Effects of angiotensin II type 1 receptor blockade in ApoE-deficient mice with post-ischemic heart failure

Author keywords

Angiotensin II AT1 receptor blockade; Atherosclerosis; Heart failure; Hemodynamics; Mortality; Mouse

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; IRBESARTAN; VALSARTAN;

EID: 0037716405     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200307000-00003     Document Type: Article
Times cited : (5)

References (32)
  • 1
    • 0021828444 scopus 로고
    • Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril
    • Pfeffer MA, Pfeffer JM, Steinberg C, et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-412.
    • (1985) Circulation , vol.72 , pp. 406-412
    • Pfeffer, M.A.1    Pfeffer, J.M.2    Steinberg, C.3
  • 2
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
    • CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
    • (1987) N Engl J Med , vol.316 , pp. 1429-1435
  • 3
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
    • SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.
    • (1992) N Engl J Med , vol.327 , pp. 669-677
  • 4
    • 0030902115 scopus 로고    scopus 로고
    • Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
    • Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
    • (1997) Lancet , vol.349 , pp. 747-752
    • Pitt, B.1    Segal, R.2    Martinez, F.A.3
  • 5
    • 0032928804 scopus 로고    scopus 로고
    • 1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats
    • 1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc Res. 1999;41:100-108.
    • (1999) Cardiovasc Res , vol.41 , pp. 100-108
    • Richer, C.1    Fornes, P.2    Cazaubon, C.3
  • 6
    • 0036156918 scopus 로고    scopus 로고
    • Use of angiotensin II receptor blockers in animal models of atherosclerosis
    • Ferrario CM. Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens. 2002;15:9S-13S.
    • (2002) Am J Hypertens , vol.15
    • Ferrario, C.M.1
  • 7
    • 0031591667 scopus 로고    scopus 로고
    • The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
    • Keidar S, Attias J, Smith J, et al. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 1997;236:622-626.
    • (1997) Biochem Biophys Res Commun , vol.236 , pp. 622-626
    • Keidar, S.1    Attias, J.2    Smith, J.3
  • 8
    • 0033408540 scopus 로고    scopus 로고
    • The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
    • Hayek T, Attias J, Coleman R, et al. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res. 1999;44:579-587.
    • (1999) Cardiovasc Res , vol.44 , pp. 579-587
    • Hayek, T.1    Attias, J.2    Coleman, R.3
  • 9
    • 17944364485 scopus 로고    scopus 로고
    • 1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice
    • 1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2001;38:395-405.
    • (2001) J Cardiovasc Pharmacol , vol.38 , pp. 395-405
    • Dol, F.1    Martin, G.2    Staels, B.3
  • 10
    • 0037165228 scopus 로고    scopus 로고
    • Angiotensin trials of cardiovascular outcomes
    • Sleight P. Angiotensin II and trials of cardiovascular outcomes. Am J Cardiol. 2002;89(Suppl.):11A-17A.
    • (2002) Am J Cardiol , vol.89 , Issue.SUPPL.
    • Sleight P. II1
  • 11
    • 0027465551 scopus 로고
    • Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham Study
    • Cupples LA, Gagnon DR, Wong ND, et al. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham Study. Am Heart J. 1993;125:863-872.
    • (1993) Am Heart J , vol.125 , pp. 863-872
    • Cupples, L.A.1    Gagnon, D.R.2    Wong, N.D.3
  • 12
    • 0027958084 scopus 로고
    • ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
    • Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
    • (1994) Arterioscler Thromb , vol.14 , pp. 133-140
    • Nakashima, Y.1    Plump, A.S.2    Raines, E.W.3
  • 13
    • 0033030356 scopus 로고    scopus 로고
    • Chronic myocardial infarction in the mouse: Cardiac structural and functional changes
    • Lutgens E, Daemen MJAP, De Muinck ED, et al. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res. 1999;41:586-593.
    • (1999) Cardiovasc Res , vol.41 , pp. 586-593
    • Lutgens, E.1    Daemen, M.J.A.P.2    De Muinck, E.D.3
  • 15
    • 0033984947 scopus 로고    scopus 로고
    • Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice
    • Gao XM, Dart AM, Dewar E, et al. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res. 2000;45:330-338.
    • (2000) Cardiovasc Res , vol.45 , pp. 330-338
    • Gao, X.M.1    Dart, A.M.2    Dewar, E.3
  • 16
    • 0035947745 scopus 로고    scopus 로고
    • Diminished cardioprotective response to in-hibition of angiotensin-converting enzyme and angiotensin II type 1 recep-tor in B(2) kinin receptor gene knockout mice
    • Yang XP, Liu YH, Mehta D, et al. Diminished cardioprotective response to in-hibition of angiotensin-converting enzyme and angiotensin II type 1 recep-tor in B(2) kinin receptor gene knockout mice. Circ Res. 2001;88:1072-1079.
    • (2001) Circ Res , vol.88 , pp. 1072-1079
    • Yang, X.P.1    Liu, Y.H.2    Mehta, D.3
  • 17
    • 0036175376 scopus 로고    scopus 로고
    • Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure
    • Liu YH, Xu J, Yang XP, et al. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension. 2002;39:375-381.
    • (2002) Hypertension , vol.39 , pp. 375-381
    • Liu, Y.H.1    Xu, J.2    Yang, X.P.3
  • 18
    • 0026592806 scopus 로고
    • Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
    • Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
    • (1992) Science , vol.258 , pp. 468-471
    • Zhang, S.H.1    Reddick, R.L.2    Piedrahita, J.A.3
  • 19
    • 0029618704 scopus 로고
    • Myocardial ischemia and reperfusion: A murine model
    • Michael LH, Entman ML, Hartley CJ, et al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995;269:H2147-H2154.
    • (1995) Am J Physiol , vol.269
    • Michael, L.H.1    Entman, M.L.2    Hartley, C.J.3
  • 20
    • 0033975483 scopus 로고    scopus 로고
    • Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques
    • Davi H, Tronquet C, Miscoria G, et al. Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques. Drug Metab Dispos. 1999;28:79-88.
    • (1999) Drug Metab Dispos , vol.28 , pp. 79-88
    • Davi, H.1    Tronquet, C.2    Miscoria, G.3
  • 21
    • 0024723470 scopus 로고
    • Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
    • American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
    • Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
    • (1989) J Am Soc Echocardiogr , vol.2 , pp. 358-367
    • Schiller, N.B.1    Shah, P.M.2    Crawford, M.3
  • 22
    • 0033840444 scopus 로고    scopus 로고
    • Fluospheres for cardiovascular phenotyping genetically modified mice
    • Richer C, Domergue V, Gervais M, et al. Fluospheres for cardiovascular phenotyping genetically modified mice. J Cardiovasc Pharmacol. 2000;36:396-404.
    • (2000) J Cardiovasc Pharmacol , vol.36 , pp. 396-404
    • Richer, C.1    Domergue, V.2    Gervais, M.3
  • 23
    • 0026681044 scopus 로고
    • Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats
    • Richer C, Mulder P, Fornes P et al. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol. 1992;20:147-156.
    • (1992) J Cardiovasc Pharmacol , vol.20 , pp. 147-156
    • Richer, C.1    Mulder, P.2    Fornes, P.3
  • 24
    • 0032168737 scopus 로고    scopus 로고
    • Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice
    • Nicoletti A, Kaveri S, Caligiuri G, et al. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest. 1998;102:910-918.
    • (1998) J Clin Invest , vol.102 , pp. 910-918
    • Nicoletti, A.1    Kaveri, S.2    Caligiuri, G.3
  • 25
    • 0015295291 scopus 로고
    • Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I
    • Ménard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinolog. 1972;90:422-430.
    • (1972) Endocrinolog , vol.90 , pp. 422-430
    • Ménard, J.1    Catt, K.J.2
  • 26
    • 9844227496 scopus 로고
    • Chi-square tests with one degree of freedom: Extension of the Mantel-Haenszel procedure
    • Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58:690-700.
    • (1963) J Am Stat Assoc , vol.58 , pp. 690-700
    • Mantel, N.1
  • 27
    • 0032966298 scopus 로고    scopus 로고
    • Systematic review on the risk and benefit of different cholesterol-lowering interventions
    • Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol. 1999;19:187-195.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 187-195
    • Bucher, H.C.1    Griffith, L.E.2    Guyatt, G.H.3
  • 28
    • 0032725149 scopus 로고    scopus 로고
    • Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice
    • Girod WG, Jones SP, Sieber N, et al. Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:2776-2781.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 2776-2781
    • Girod, W.G.1    Jones, S.P.2    Sieber, N.3
  • 29
    • 0032564279 scopus 로고    scopus 로고
    • Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
    • Barton M, Haudenschild CC, d'Uscio LV, et al. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci. 1998;95:14367-14372.
    • (1998) Proc Natl Acad Sci , vol.95 , pp. 14367-14372
    • Barton, M.1    Haudenschild, C.C.2    D'Uscio, L.V.3
  • 31
    • 0032718549 scopus 로고    scopus 로고
    • Hypertension and endothelial dysfunction in apolipoprotein E knockout mice
    • Yang R, Powell-Braxton L, Ogaoawara AK, et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 1999;19:2762-2768.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 2762-2768
    • Yang, R.1    Powell-Braxton, L.2    Ogaoawara, A.K.3
  • 32
    • 0033920866 scopus 로고    scopus 로고
    • Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study
    • Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58:293-301.
    • (2000) Kidney Int , vol.58 , pp. 293-301
    • Muntner, P.1    Coresh, J.2    Smith, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.